Kristen K. Buck

2022

In 2022, Kristen K. Buck earned a total compensation of $1.1M as Executive Vice President of Research Development and Chief Medical Officer at Caladrius Biosciences.

Compensation breakdown

Bonus$376,388
Option Awards$20,122
Salary$553,781
Stock Awards$165,560
Other$8,250
Total$1,124,102
49.26%

Buck received $553.8K in salary, accounting for 49% of the total pay in 2022.

Buck also received $376.4K in bonus, $20.1K in option awards, $165.6K in stock awards and $8.3K in other compensation.

Rankings

In 2022, Kristen K. Buck's compensation ranked 2,810th out of 5,758 executives tracked by ExecPay. In other words, Buck earned more than 51.2% of executives.

ClassificationRankingPercentile
All
2,810
out of 5,758
51st
Division
Manufacturing
1,568
out of 3,135
50th
Major group
Chemicals And Allied Products
727
out of 1,421
49th
Industry group
Drugs
679
out of 1,322
49th
Industry
Pharmaceutical Preparations
492
out of 968
49th
Source: SEC filing on April 29, 2024.

Buck's colleagues

We found two more compensation records of executives who worked with Kristen K. Buck at Caladrius Biosciences in 2022.

2022

David Mazzo

Caladrius Biosciences

Chief Executive Officer

2022

David Slack

Caladrius Biosciences

Former President and Chief Business Officer

News

You may also like